The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)
Just last week, ConsortiEX proudly announced our new InsightRX Passive Audit Monitoring module.
ConsortiEX is proudly attending ASHP Midyear. Stop by Booth 900 to see how our intuitive Pharmacy-Focused ERP solutions can enhance your patient safety, ensure quality control, and simplify compliance, first-hand and in-person. Our new InsightRX Passive Audit Monitoring hood will be on display.
Introducing InsightRX Passive Audit Monitoring: See what others miss.
The practice of compounding medicines can provide important public health opportunities. The FDA’s compounding program – including implementation of the compounding provisions of the law – is a priority for the agency. We recognize that in delivering on implementation commitments, we must balance the need to preserve[...]
We want to thank everybody who came to visit our booth at this year’s ASHP Summer Meetings & Exhibition.
We recently sat down with ConsortiEX CEO, Neal Long, to discuss the company’s background and learn more about its plans to help hospitals safely distribute, source and track compounded pharmaceuticals among affiliated hospitals. addresses the worldwide problem of drug availability, patient safety and high costs. The[...]